Published in Emerg Infect Dis on February 01, 2004
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev (2005) 3.18
Antibodies to SARS coronavirus in civets. Emerg Infect Dis (2004) 2.27
Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J Virol (2005) 1.79
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev (2007) 1.68
Animal models and vaccines for SARS-CoV infection. Virus Res (2007) 1.50
Wrestling SARS from uncertainty. Emerg Infect Dis (2004) 1.50
Cynomolgus macaque as an animal model for severe acute respiratory syndrome. PLoS Med (2006) 1.40
Review of bats and SARS. Emerg Infect Dis (2006) 1.38
Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates. J Virol (2005) 1.32
Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virol (2004) 1.28
Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2. J Virol (2004) 1.28
Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice. Am J Pathol (2008) 1.12
Plaque assay for human coronavirus NL63 using human colon carcinoma cells. Virol J (2008) 1.05
Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. J Virol (2006) 1.01
Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses. Expert Opin Biol Ther (2009) 0.98
Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products. Biologicals (2011) 0.79
A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68
The molecular biology of coronaviruses. Adv Virus Res (1997) 6.62
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52
A new model for coronavirus transcription. Adv Exp Med Biol (1998) 2.75
Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology (2000) 2.59
Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma. Nat Med (1999) 2.53
Sites of replication of a porcine respiratory coronavirus in 5-week-old pigs with or without maternal antibodies. Adv Exp Med Biol (1990) 0.87
Infection with a new porcine respiratory coronavirus in Denmark: serologic differentiation from transmissible gastroenteritis virus using monoclonal antibodies. Adv Exp Med Biol (1990) 0.87
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40
Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis (2007) 3.47
Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype. Virology (2005) 3.14
West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ (2003) 3.03
Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008. Emerg Infect Dis (2010) 2.17
Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs. J Infect Dis (2011) 2.10
Disease modeling for Ebola and Marburg viruses. Dis Model Mech (2009) 2.07
Intersegmental recombination between the haemagglutinin and matrix genes was responsible for the emergence of a highly pathogenic H7N3 avian influenza virus in British Columbia. J Gen Virol (2005) 2.06
Genetic and pathobiologic characterization of pandemic H1N1 2009 influenza viruses from a naturally infected swine herd. J Virol (2009) 1.76
Developments in diagnostic techniques for differentiating infection from vaccination in foot-and-mouth disease. Vet J (2004) 1.67
Transmission of Ebola virus from pigs to non-human primates. Sci Rep (2012) 1.66
An outbreak of West Nile virus-associated disease in domestic geese (Anser anser domesticus) upon initial introduction to a geographic region, with evidence of bird to bird transmission. Can Vet J (2004) 1.55
Hendra virus outbreak with novel clinical features, Australia. Emerg Infect Dis (2010) 1.53
Wild bird influenza survey, Canada, 2005. Emerg Infect Dis (2008) 1.45
Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus. J Infect Dis (2010) 1.43
Identifying Hendra virus diversity in pteropid bats. PLoS One (2011) 1.40
Characterization of experimental equine glanders. Microbes Infect (2003) 1.37
Molecular characterization of pandemic H1N1 influenza viruses isolated from turkeys and pathogenicity of a human pH1N1 isolate in turkeys. Avian Dis (2010) 1.35
Comparison of assays for the detection of West Nile virus antibodies in chicken serum. Can J Vet Res (2003) 1.33
Features predicting weight loss in overweight or obese participants in a web-based intervention: randomized trial. J Med Internet Res (2012) 1.31
Invasion of the central nervous system in a porcine host by nipah virus. J Virol (2005) 1.30
Experimental infection of pigs with the human 1918 pandemic influenza virus. J Virol (2009) 1.29
Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virol (2004) 1.28
Recombinant nipah virus vaccines protect pigs against challenge. J Virol (2006) 1.25
Entomological investigations in a focus of dengue transmission in Cairns, Queensland, Australia, by using the sticky ovitraps. J Med Entomol (2004) 1.24
Sequence determination of the Crimean-Congo hemorrhagic fever virus L segment. Virology (2004) 1.24
Ubiquitous activation of the Nipah virus fusion protein does not require a basic amino acid at the cleavage site. J Virol (2004) 1.18
Susceptibility of Canada Geese (Branta canadensis) to highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis (2007) 1.18
Molecular, biochemical and genetic characteristics of BSE in Canada. PLoS One (2010) 1.15
Temporal- and strain-specific host microRNA molecular signatures associated with swine-origin H1N1 and avian-origin H7N7 influenza A virus infection. J Virol (2012) 1.12
Characterization of H1N1 swine influenza viruses circulating in Canadian pigs in 2009. J Virol (2011) 1.11
Emerging and re-emerging infectious diseases. Med Microbiol Immunol (2002) 1.09
A seroprevalence study of west nile virus infection in solid organ transplant recipients. Am J Transplant (2004) 1.09
Characterization of low-pathogenicity H5N1 avian influenza viruses from North America. J Virol (2007) 1.08
Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza. Sci Transl Med (2013) 1.08
Highly pathogenic avian influenza virus A (H7N3) in domestic poultry, Saskatchewan, Canada, 2007. Emerg Infect Dis (2009) 1.07
Design of oligonucleotide arrays to detect point mutations: molecular typing of antibiotic resistant strains of Neisseria gonorrhoeae and hantavirus infected deer mice. Mol Cell Probes (2003) 1.06
Animal models of henipavirus infection: a review. Vet J (2008) 1.05
Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus. J Infect Dis (2011) 1.03
Distribution and phylogenetic comparisons of a novel mosquito flavivirus sequence present in Culex tarsalis Mosquitoes from western Canada with viruses isolated in California and Colorado. Am J Trop Med Hyg (2011) 1.01
Understanding endorphins and their importance in pain management. Hawaii Med J (2010) 1.01
Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus. J Virol Methods (2004) 0.99
Clinical utility of commercial enzyme immunoassays during the inaugural season of West Nile virus activity, Alberta, Canada. J Clin Microbiol (2005) 0.98
The roles of national and provincial diagnostic laboratories in the eradication of highly pathogenic H7N3 avian influenza virus from the Fraser Valley of British Columbia, Canada. Avian Dis (2007) 0.96
A multiplex DNA suspension microarray for simultaneous detection and differentiation of classical swine fever virus and other pestiviruses. J Virol Methods (2006) 0.96
Microglial cell activation in demyelinating canine distemper lesions. J Neuroimmunol (2004) 0.96
The large-display user experience. IEEE Comput Graph Appl (2005) 0.95
Bartonella australis sp. nov. from kangaroos, Australia. Emerg Infect Dis (2007) 0.95
Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems. Vaccine (2008) 0.95
The effect of initial local anesthetic dose with continuous interscalene analgesia on postoperative pain and diaphragmatic function in patients undergoing arthroscopic shoulder surgery: a double-blind, randomized controlled trial. BMC Anesthesiol (2012) 0.95
Innate immune response to Rift Valley fever virus in goats. PLoS Negl Trop Dis (2012) 0.93
Zoonotic infections in native communities of James Bay, Canada. Vector Borne Zoonotic Dis (2012) 0.92
Construction and characterization of an infectious murine gammaherpesivrus-68 bacterial artificial chromosome. J Biomed Biotechnol (2010) 0.91
A preliminary study of the patterns of Sin Nombre viral infection and shedding in naturally infected deer mice (Peromyscus maniculatus). Vector Borne Zoonotic Dis (2005) 0.91
Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003. Can J Public Health (2006) 0.90
Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus. J Virol Methods (2005) 0.90
Seroprevalence of 10 zoonotic infections in 2 Canadian Cree communities. Diagn Microbiol Infect Dis (2011) 0.89
Yemen and Vietnam capripoxviruses demonstrate a distinct host preference for goats compared with sheep. J Gen Virol (2009) 0.89
Cytotoxicity of ORF3 proteins from a nonpathogenic and a pathogenic porcine circovirus. J Virol (2010) 0.88
Lentiviral airway gene transfer in lungs of mice and sheep: successes and challenges. J Gene Med (2010) 0.88
Pleural fluid nucleic acid testing enhances pneumococcal surveillance in children. Respirology (2012) 0.88
A single electroporation delivery of a DNA vaccine containing the hemagglutinin gene of Asian H5N1 avian influenza virus generated a protective antibody response in chickens against a North American virus strain. Clin Vaccine Immunol (2013) 0.88
Ross River virus disease reemergence, Fiji, 2003-2004. Emerg Infect Dis (2005) 0.87
Lung disease associated with periventricular nodular heterotopia and an FLNA mutation. Eur J Med Genet (2010) 0.87
Bacterial causes of empyema in children, Australia, 2007-2009. Emerg Infect Dis (2011) 0.87
Roles of host species, geographic separation, and isolation in the seroprevalence of Jamestown Canyon and snowshoe hare viruses in Newfoundland. Appl Environ Microbiol (2012) 0.86
Development and evaluation of one-step rRT-PCR and immunohistochemical methods for detection of Rift Valley fever virus in biosafety level 2 diagnostic laboratories. J Virol Methods (2011) 0.85
Detection of low pathogenic avian influenza viruses in wild ducks from Canada: comparison of two sampling methods. J Wildl Dis (2011) 0.85
Development and use of a biotinylated 3ABC recombinant protein in a solid-phase competitive ELISA for the detection of antibodies against foot-and-mouth disease virus. J Virol Methods (2004) 0.84
The development and validation of sexual health indicators of Canadians aged 16-24 years. Public Health Rep (2013) 0.84
Prognosis of West Nile virus associated acute flaccid paralysis: a case series. J Med Case Rep (2011) 0.84
Antibody responses of pigs to defined Erns fragments after infection with classical swine fever virus. Clin Diagn Lab Immunol (2005) 0.84
Molecular and antigenic characterization of reassortant H3N2 viruses from turkeys with a unique constellation of pandemic H1N1 internal genes. PLoS One (2012) 0.83
A preliminary report on the effects of paclitaxel-impregnated stents on sheep nasal mucosa. Am J Rhinol (2004) 0.83
Induction of Toll-like receptor 4 signaling in avian macrophages inhibits infectious laryngotracheitis virus replication in a nitric oxide dependent way. Vet Immunol Immunopathol (2013) 0.83
Cloning, expression and immunoassay detection of ferret IFN-gamma. Dev Comp Immunol (2008) 0.82
Infants with chronic neonatal lung disease: recommendations for the use of home oxygen therapy. Med J Aust (2008) 0.82
Evaluation of diagnostic applications of monoclonal antibodies against avian influenza H7 viruses. Clin Vaccine Immunol (2010) 0.81
Pre-exposing Canada Geese (Branta canadensis) to a low-pathogenic H1N1 avian influenza virus protects them against H5N1 HPAI virus challenge. J Wildl Dis (2013) 0.81
Comparison of reverse transcriptase-polymerase chain reaction, virus isolation, and immunoperoxidase assays for detecting pigs infected with low, moderate, and high virulent strains of classical swine fever virus. J Vet Diagn Invest (2004) 0.81
Use of a SLAM transfected Vero cell line to isolate and characterize marine mammal morbilliviruses using an experimental ferret model. J Wildl Dis (2008) 0.81
Characterization of canine microglial cells isolated ex vivo. Vet Immunol Immunopathol (2004) 0.81
Identification of antigenic regions of the Erns protein for pig antibodies elicited during classical swine fever virus infection. J Biochem (2004) 0.81
The atypical anti-psychotic clozapine decreases bone mass in rats in vivo. Schizophr Res (2010) 0.81